The Prognostic Value of the Systemic Inflammatory Response in Randomised Clinical Trials in Cancer: A Systematic Review

Critical Reviews in Oncology/Hematology - Netherlands
doi 10.1016/j.critrevonc.2018.09.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phytotherapeutic Interventions in the Management of Biochemically Recurrent Prostate Cancer: A Systematic Review of Randomised Trials

BJU International
Urology
2016English

Clinical Value of lncRNA MALAT1 as a Prognostic Marker in Human Cancer: Systematic Review and Meta-Analysis

BMJ Open
Medicine
2015English

Variation in Hyperemesis Gravidarum Definition and Outcome Reporting in Randomised Clinical Trials: A Systematic Review

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2018English

Prognostic Value of microRNAs in Lung Cancer: A Systematic Review and Meta‑analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

Improving the Recruitment Activity of Clinicians in Randomised Controlled Trials: A Systematic Review

BMJ Open
Medicine
2012English

Systemic Antioxidants in Management of Oral Submucous Fibrosis: A Systematic Review of Randomised Control Trials and Meta–analysis.

International Journal of Advanced Research
2017English

Prognostic Value of Perineural Invasion in Gastric Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis

Gastroenterology Research and Practice
HepatologyGastroenterology
2018English

P09.31 the Prognostic Value of Systemic Inflammatory Indices in Recurrent Glioma Treated With Bevacizumab

Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy